Lingbiao Xin

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Breast Cancer Cells

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

Medical oncology (Northwood, London, England)

Science advances

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Lihong Hu, Yufeng Zeng, Lingbiao Xin, Jie Yang
SND1, a novel co-activator of HIF1α, promotes tumor initiation in PyMT-induced breast tumor. The FEBS journal (2023)
Chuanbo Ha, Lihong Hu, Yuanyuan Ren, Jie Yang, Lingbiao Xin
SND1 confers chemoresistance to cisplatin-induced apoptosis by targeting GAS6-AKT in SKOV3 ovarian cancer cells. Medical oncology (Northwood, London, England) 39 (11) (2022)
Yuan Wang, Xinting Wang, Xiaoteng Cui, Yue Zhuo, Hongshuai Li, Chuanbo Ha, Lingbiao Xin, Yuanyuan Ren, Wei Zhang, Xiaoming Sun, Lin Ge, Xin Liu, Jinyan He, Tao Zhang, Kai Zhang, Zhi Yao, Xi Yang, Jie Yang
Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor. Science advances 6 (22) (2020)